STVN Stock Analysis: Buy, Sell, or Hold?
STVN - Stevanato Group S.p.A.
$19.78
0.19 (0.97%)
▲
5d:
+2.59%
30d:
+14.67%
90d:
+46.3%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
21d
Get Alerted When STVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: STVN shows positive signals but monitor for confirmation. Market pricing in 2.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: STVN shows positive signals but monitor for confirmation. Market pricing in 2.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.49
Based on 11.5% avg growth
INTRINSIC VALUE TODAY
$19.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: STVN is currently trading at $19.78, which is considered extended relative to its 30-day fair value range of $17.05 to $19.08. The stock's valuation (Forward PE: 23.4) is in line with its historical norms (22.0). At these levels, the market is pricing in 2.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, STVN is in a strong uptrend. The price is approaching resistance at $20.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: STVN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.45 (+24.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, STVN is in a strong uptrend. The price is approaching resistance at $20.27. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: STVN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.45 (+24.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$17.05 -
$19.08
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.8% below Wall St target ($24.45)
- NEUTRAL: Market pricing in 2.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$17.05 -
$19.08
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.23
Resistance Level
$20.27
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.45
Wall Street Target
$24.45
(+24.8%)
Revenue Growth (YoY)
6.6%
Earnings Growth (YoY)
2.9%
Profit Margin
11.8%
Valuation Premium vs History
+2.1% premium
PE vs Historical
23.5 vs 22.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.1%
(market-implied from PE analysis)
1-Year Target
$20.00
(+2%)
2-Year Target
$20.42
(+4%)
3-Year Target
$20.85
(+6%)
3-Yr Target (if PE normalizes)
(PE: 23→22)
PE COMPRESSION
$19.56
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.5, Growth: 19.0%)
$32.97
(+68%)
Base:
(SPY PE: 21.8, Growth: 19.0%)
$30.62
(+56%)
Bear:
(PE: 18.5, Growth: 19.0%)
$26.03
(+33%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 34.05 | Current EPS (TTM): $0.58
Bull Case
$31.29
(+60%)
Analyst growth 44.0%, PE expands to 37.5
Base Case
$28.44
(+45%)
Market implied 44.0%, PE stable at 34.1
Bear Case
$13.43
(-31%)
Severe decline -20.0%, PE contracts to 28.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 4:21 PM ET
Data refreshes hourly during market hours. Next update: 5:21 PM
Data refreshes hourly during market hours. Next update: 5:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$562 | 63 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 61 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$177 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$366 | 63 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 61 BUY |
